Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,544 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immediate or staged complete revascularisation in patients presenting with acute coronary syndrome by number of diseased vessels: a substudy of the BIOVASC randomised trial.
Kakar H, Elscot JJ, Scarparo P, Den Dekker WK, Bennett J, Sabaté M, Esposito G, Amat-Santos I, Boersma E, Van Mieghem NM, Diletti R. Kakar H, et al. Among authors: bennett j. EuroIntervention. 2024 Apr 15;20(8):e479-e486. doi: 10.4244/EIJ-D-23-00762. EuroIntervention. 2024. PMID: 38629415 Free article. Clinical Trial.
Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial.
Adriaenssens T, Dens J, Ughi G, Bennett J, Dubois C, Sinnaeve P, Wiyono S, Coosemans M, Belmans A, D'hooge J, Vrolix M, Desmet W. Adriaenssens T, et al. Among authors: bennett j. EuroIntervention. 2014 Aug;10(4):439-48. doi: 10.4244/EIJV10I4A77. EuroIntervention. 2014. PMID: 25138182 Free article. Clinical Trial.
STACCATO (Assessment of Stent sTrut Apposition and Coverage in Coronary ArTeries with Optical coherence tomography in patients with STEMI, NSTEMI and stable/unstable angina undergoing everolimus vs. biolimus A9-eluting stent implantation): a randomised controlled trial.
Adriaenssens T, Ughi GJ, Dubois C, De Cock D, Onsea K, Bennett J, Wiyono S, Sinnaeve P, Coosemans M, Ferdinande B, Belmans A, D'hooge J, Desmet W. Adriaenssens T, et al. Among authors: bennett j. EuroIntervention. 2016 Apr 8;11(14):e1619-26. doi: 10.4244/EIJY14M11_11. EuroIntervention. 2016. PMID: 25420791 Free article. Clinical Trial.
COmplex coronary Bifurcation lesions: RAndomized comparison of a strategy using a dedicated self-expanding biolimus-eluting stent versus a culotte strategy using everolimus-eluting stents: primary results of the COBRA trial.
Dubois C, Bennett J, Dens J, De Cock D, Desmet W, Belmans A, Ughi GJ, Sinnaeve P, Vrolix M, D'hooge J, Adriaenssens T. Dubois C, et al. Among authors: bennett j. EuroIntervention. 2016 Apr 20;11(13):1457-67. doi: 10.4244/EIJY15M05_02. EuroIntervention. 2016. PMID: 25947278 Free article. Clinical Trial.
Optical coherence tomography findings: insights from the "randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions" (PRISON IV) trial.
Teeuwen K, Spoormans EM, Bennett J, Dubois C, Desmet W, Ughi GJ, Belmans A, Kelder JC, Tijssen JGP, Agostoni P, Suttorp MJ, Adriaenssens T. Teeuwen K, et al. Among authors: bennett j. EuroIntervention. 2017 Aug 4;13(5):e522-e530. doi: 10.4244/EIJ-D-17-00261. EuroIntervention. 2017. PMID: 28512069 Free article. Clinical Trial.
Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial.
Kandzari DE, Mauri L, Koolen JJ, Massaro JM, Doros G, Garcia-Garcia HM, Bennett J, Roguin A, Gharib EG, Cutlip DE, Waksman R; BIOFLOW V Investigators. Kandzari DE, et al. Among authors: bennett j. Lancet. 2017 Oct 21;390(10105):1843-1852. doi: 10.1016/S0140-6736(17)32249-3. Epub 2017 Aug 26. Lancet. 2017. PMID: 28851504 Clinical Trial.
Percutaneous complete revascularization strategies using sirolimus-eluting biodegradable polymer-coated stents in patients presenting with acute coronary syndrome and multivessel disease: Rationale and design of the BIOVASC trial.
den Dekker WK, Van Mieghem NM, Bennett J, Sabate M, Esposito G, van Bommel RJ, Daemen J, Vrolix M, Cummins PA, Lenzen MJ, Boersma E, Zijlstra F, Diletti R; BioVasc Trial Investigators. den Dekker WK, et al. Among authors: bennett j. Am Heart J. 2020 Sep;227:111-117. doi: 10.1016/j.ahj.2020.06.006. Epub 2020 Jun 15. Am Heart J. 2020. PMID: 32739537 Free article.
5,544 results